Abstract
Esthesioneuroblastoma (ENB) is the most frequent cancer of the nasal cavity in children, with an estimated incidence of 0.1 per 100,000 children up to 15 years. It is thought to arise from the olfactory neuroepithelium, and it is morphologically similar to neuroblastoma, but biology is different. ENB seems to be more aggressive in children than in adults and can spread to the paranasal sinuses and into the cranial cavity. Nodal involvement is present in up to 25% of children, but distant metastases are rare. MRI is important to delineate the extent of the disease. MIBG scintigraphy is typically negative. The Kadish staging system is used: (a) tumors confined to the nasal cavity, (b) tumors infiltrate the paranasal cavities, (c) tumors extend beyond the nasal and paranasal cavities, and (d) tumors with metastases. Complete resection is important but often difficult to achieve. Modern radiation techniques such as intensity-modulated radiotherapy or proton therapy should be considered. Sarcoma or neuroblastoma-like chemotherapy regimens have been used with similar results, completing the necessary multidisciplinary approach that has progressively improved the outcome of children with ENB. Long-term sequelae including impaired craniofacial growth, endocrine dysfunctions, and loss of sense of smell are common.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Argani P, Perez-Ordoñez B, Xiao H, Caruana SM, Huvos AG, Ladanyi M (1998) Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol 22:391–398
Bachar G, Goldstein DP, Shah M, Tandon A, Ringash J, Pond G, Gullane PJ, Perez-Ordonez B, Gilbert RW, Brown DH, Gentili F, O’Sullivan B, Irish JC (2008) Esthesioneuroblastoma: the Princess Margaret Hospital experience. Head Neck 30:1607–1614
Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, Hanna EY (2015) Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 9:51–59
Benoit MM, Bhattacharyya N, Faquin W, Cunningham M (2008) Cancer of the nasal cavity in the pediatric population. Pediatrics 121:e141–e145
Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC (1997) Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch Otolaryngol Head Neck Surg 123:34–40
Biller HF, Lawson W, Sachdev VP, Som P (1990) Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 100:1199–1201
Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, Luksch R, Cecchetto G (2012) Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer 12:117
Bradley PJ, Jones NS, Robertson I (2003) Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg 11:112–118
Broich G, Pagliari A, Ottaviani F (1997) Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 17:2683–2706
Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ (2012) The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med 53:1200–1206
Buckner JC, Peethambaram PP, Smithson WA, Groover RV, Schomberg PJ, Kimmel DW, Raffel C, O’Fallon JR, Neglia J, Shaw EG (1999) Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol 17:933–940
Chao KS, Kaplan C, Simpson JR, Haughey B, Spector GJ, Sessions DG, Arquette M (2001) Esthesioneuroblastoma: the impact of treatment modality. Head Neck 23:749–757
Cohen ZR, Marmor E, Fuller GN, DeMonte F (2002) Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus 12:e3
Czapiewski P, Kunc M, Gorczyński A, Haybaeck J, Okoń K, Reszec J, Lewczuk A, Dzierzanowski J, Karczewska J, Biernat W, Turri-Zanoni M, Castelnuovo P, Taverna C, Franchi A, La Rosa S, Sessa F, Klöppel G (2018) Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature. Hum Pathol 79:144–150
Devaiah AK, Andreoli MT (2009) Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope 119:1412–1416
Dulguerov P, Calcaterra T (1992) Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 102:843–849
Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2:683–690
Dumont B, Fresneau B, Claude L, Defachelles AS, Couloigner V, Puget S, Brisse HJ, Fréneaux P, Lacour B, Orbach D (2020a) Pattern of loco-regional relapses and treatment in pediatric esthesioneuroblastoma: the French very rare tumors group (fracture) contribution. Pediatr Blood Cancer 67:e28154
Dumont B, Lemelle L, Cordero C, Couloigner V, Bernard S, Cardoen L, Brisse HJ, Jehanno N, Fréneaux P, Helfre S, Rouffiange L, Réguerre Y, Orbach D (2020b) Esthesioneuroblastoma in children, adolescents and young adults. Bull Cancer 107:934–945
Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, Cantrell RW, Constable WC (1994) Esthesioneuroblastoma. Long-term outcome and patterns of failure—the University of Virginia experience. Cancer 73:2556–2562
Eich HT, Staar S, Micke O, Eich PD, Stützer H, Müller R (2001) Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 49:155–160
Eich HT, Hero B, Staar S, Micke O, Seegenschmiedt H, Mattke A, Berthold F, Müller RP (2003) Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Strahlenther Onkol 179:233–240
Eich HT, Müller RP, Micke O, Kocher M, Berthold F, Hero B (2005) Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment. Strahlenther Onkol 181:378–384
El Kababri M, Habrand JL, Valteau-Couanet D, Gaspar N, Dufour C, Oberlin O (2014) Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review. J Pediatr Hematol Oncol 36:91–95
Faragalla H, Weinreb I (2009) Olfactory neuroblastoma: a review and update. Adv Anat Pathol 16:322–331
Ferlito A, Rinaldo A, Rhys-Evans PH (2003) Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck. Laryngoscope 113:1935–1938
Fiani B, Quadri SA, Cathel A, Farooqui M, Ramachandran A, Siddiqi I, Ghanchi H, Zafar A, Berman BW, Siddiqi J (2019) Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current treatment options. World Neurosurg 126:194–211
Folbe A, Herzallah I, Duvvuri U, Bublik M, Sargi Z, Snyderman CH, Carrau R, Casiano R, Kassam AB, Morcos JJ (2009) Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy 23:91–94
Foote RL, Morita A, Ebersold MJ, Olsen KD, Lewis JE, Quast LM, Ferguson JA, O’Fallon WM (1993) Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 27:835–842
Freeman SR, Mitra S, Malik TH, Flanagan P, Selby P (2005) Expression of somatostatin receptors in arginine vasopressin hormone-secreting olfactory neuroblastoma—report of two cases. Rhinology 43:61–65
Goldsweig HG, Sundaresan N (1990) Chemotherapy of recurrent esthesioneuroblastoma. Case report and review of the literature. Am J Clin Oncol 13:139–143
Gore MR, Zanation AM (2009) Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol Head Neck Surg 135:1030–1034
Holmes M, Su SY, Bell D (2016) Ectopic primary olfactory neuroblastoma of the maxillary sinus. Ann Diagn Pathol 22:45–48
Hyams, VJ, Batsakis JG, Michaels L (1988) Olfactory neuroblastoma. In: Tumors of the upper respiratory tract and ear, Fascicle 25, Second Series. Armed Forces Institute of Pathology, Washington, DC, p 240–248.
Jethanamest D, Morris LG, Sikora AG, Kutler DI (2007) Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 133:276–280
Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37:1571–1576
Kairemo KJ, Jekunen AP, Kestilä MS, Ramsay HA (1998) Imaging of olfactory neuroblastoma—an analysis of 17 cases. Auris Nasus Larynx 25:173–179
Kiyota N, Tahara M, Fujii S, Kawashima M, Ogino T, Minami H, Hayashi R, Ohtsu A (2008) Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases. Cancer 112:885–891
Kumar M, Fallon RJ, Hill JS, Davis MM (2002) Esthesioneuroblastoma in children. J Pediatr Hematol Oncol 24:482–487
Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R, Malone JM, Morris RT (2008) The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol 110:125–132
Lochrin C (1989) Esthesioneuroblastoma. Med Pediatr Oncol 17:433–438
Loy AH, Reibel JF, Read PW, Thomas CY, Newman SA, Jane JA, Levine PA (2006) Esthesioneuroblastoma: continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg 132:134–138
Lucas JT, Ladra MM, MacDonald SM, Busse PM, Friedmann AM, Ebb DH, Marcus KJ, Tarbell NJ, Yock TI (2015) Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer 62:1523–1528
Lund VJ, Wei WI (2015) Endoscopic surgery for malignant sinonasal tumours: an eighteen year experience. Rhinology 53:204–211
McElroy EA, Buckner JC, Lewis JE (1998) Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 42:1023–1027; discussion 1027
McLean JN, Nunley SR, Klass C, Moore C, Müller S, Johnstone PA (2007) Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg 136:998–1002
Mezzelani A, Tornielli S, Minoletti F, Pierotti MA, Sozzi G, Pilotti S (1999) Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing’s group. Br J Cancer 81:586–591
Mills SE (2002) Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 15:264–278
Miracle AC, El-Sayed IH, Glastonbury CM (2019) Diffusion weighted imaging of esthesioneuroblastoma: differentiation from other sinonasal masses. Head Neck 41:1161–1164
Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM (1993) Esthesioneuroblastoma: prognosis and management. Neurosurgery 32:706–714; discussion 714
Nelson RS, Perlman EJ, Askin FB (1995) Is esthesioneuroblastoma a peripheral neuroectodermal tumor. Hum Pathol 26:639–641
Nguyen BD, Roarke MC, Nelson KD, Chong BW (2006) F-18 FDG PET/CT staging and posttherapeutic assessment of esthesioneuroblastoma. Clin Nucl Med 31:172–174
Oskouian RJ, Jane JA, Dumont AS, Sheehan JM, Laurent JJ, Levine PA (2002) Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus 12:e4
Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A (2010) Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys 78:992–997
Peng X, Liu Y, Peng X, Wang Z, Zhang Z, Qiu Y, Jin M, Wang R, Kong D (2018) Clinical features and the molecular biomarkers of olfactory neuroblastoma. Pathol Res Pract 214:1123–1129
Ramsay HA, Kairemo KJ, Jekunen AP (1996) Somatostatin receptor imaging of olfactory neuroblastoma. J Laryngol Otol 110:1161–1163
Snyderman CH, Carrau RL, Kassam AB, Zanation A, Prevedello D, Gardner P, Mintz A (2008) Endoscopic skull base surgery: principles of endonasal oncological surgery. J Surg Oncol 97:658–664
Sterzing F, Stoiber EM, Nill S, Bauer H, Huber P, Debus J, Münter MW (2009) Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents—a single institution’s experience and a review of the literature. Radiat Oncol 4:37
Thompson LD (2009) Olfactory neuroblastoma. Head Neck Pathol 3:252–259
Tselis N, Heyd R, Baghi M, Zamboglou N (2008) Interstitial high-dose-rate-brachytherapy in advanced esthesioneuroblastoma. Laryngoscope 118:2006–2010
Van Gompel JJ, Giannini C, Olsen KD, Moore E, Piccirilli M, Foote RL, Buckner JC, Link MJ (2012) Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival. J Neurol Surg B Skull Base 73:331–336
Venkatramani R, Pan H, Furman WL, Marron JM, Haduong J, Friedrich-Medina P, Mahajan A, Bavle A, Wu H, Chintagumpala M (2016) Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer 63:465–470
Walch C, Stammberger H, Anderhuber W, Unger F, Köle W, Feichtinger K (2000) The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 110:635–640
Woerner SJ, Lazerson J, Munn RJ, Turner EA (1986) Olfactory neuroblastoma (esthesioneuroblastoma) in a 2-year-old boy. Pediatr Hematol Oncol 3:167–174
Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ (2011) Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol 35:1786–1793
Yin Z, Wang Y, Wu Y, Zhang X, Wang F, Wang P, Tao Z, Yuan Z (2018) Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis. Cancer Manag Res 10:1359–1364
Zabel A, Thilmann C, Zuna I, Schlegel W, Wannenmacher M, Debus J (2002) Comparison of forward planned conformal radiation therapy and inverse planned intensity modulated radiation therapy for esthesioneuroblastoma. Br J Radiol 75:356–361
Zanation AM, Ferlito A, Rinaldo A, Gore MR, Lund VJ, McKinney KA, Suárez C, Takes RP, Devaiah AK (2010) When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol 267:1667–1671
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hero, B., Bisogno, G., Schneider, D.T. (2022). Esthesioneuroblastoma. In: Schneider, D.T., Brecht, I.B., Olson, T.A., Ferrari, A. (eds) Rare Tumors in Children and Adolescents. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-92071-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-92071-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-92070-8
Online ISBN: 978-3-030-92071-5
eBook Packages: MedicineMedicine (R0)